Zacks Investment Research·Jun 26, 2026
Neogen Gains 101.1% in a Year: What's Driving the Rally?NEOG has surged as Food Safety growth, product launches and 3M integration support higher fiscal 2026 revenue guidance despite cost pressures.
Neogen Corporation(NEOG)Earnings, Financials & Key Ratios
NEOG•NASDAQ
$9.39
Price updated Jul 7, 2026
AboutNeogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.Show more
- Revenue$895M-3.2%
- EBITDA$135M-32.0%
- Net Income-$1.09B-11491.6%
- EPS (Diluted)-5.03-11463.2%
- Gross Margin47.1%-5.9%
- EBITDA Margin15.1%-29.7%
- Operating Margin1.05%-87.4%
- Net Margin-122.06%-11875.1%
- ROE-41.88%-13854.6%
NEOG Price & Volume
Neogen Corporation (NEOG) stock price & volume — 10-year historical chart
Loading chart...
Integration Challenges Impair Neogen's Operational Profitability
Investment Thesis • Updated 2026Q3
VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Strained
Cash Flow:Mixed
Primary Risk:Integration-driven margin erosion
Key Thesis Takeaways
- Neogen Corporation faces significant headwinds as the integration of the 3M Food Safety unit continues to pressure margins and drive revenue contraction.
- While the company maintains a stable liquidity buffer with a current ratio of 3.92, the persistent shift to negative operating income and the erosion of retained earnings to a $533.0 million deficit suggest fundamental structural challenges.
- Investors should monitor whether the company can stabilize its erratic free cash flow and reverse the downward trend in gross margins, which have compressed from 50.9% in 2024Q2 to 46.9% in 2026Q3.
Verdict Logic
the company's inability to scale operations efficiently is evidenced by a -1.6% operating margin in 2026Q3 and a persistent failure to generate consistent positive net income.
NEOG Growth Metrics
Neogen Corporation (NEOG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years12.2%
5 Years16.43%
3 Years19.28%
TTM-3.91%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-25.45%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-25.5%
Return on Capital
10 Years8.14%
5 Years3.84%
3 Years1.14%
Last Year0.25%
NEOG Recent Earnings
Neogen Corporation (NEOG) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (42%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
Apr 9, 2026Metric
Actual
Est
EPS
$0.09+125.0%
$0.04
Rev
$211M+3.3%
$204M
Q1 2026
Jan 8, 2026Metric
Actual
Est
EPS
$0.10+42.9%
$0.07
Rev
$225M+8.2%
$208M
Q4 2025
Oct 9, 2025Metric
Actual
Est
EPS
$0.04+154.1%
$0.07
Rev
$209M+3.0%
$203M
Q3 2025
Jul 29, 2025Metric
Actual
Est
EPS
$0.05-37.5%
$0.08
Rev
$225M+11.2%
$203M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 9, 2026 | $0.09vs $0.04+125.0% | $211Mvs $204M+3.3% |
| Q1 2026 | Jan 8, 2026 | $0.10vs $0.07+42.9% | $225Mvs $208M+8.2% |
| Q4 2025 | Oct 9, 2025 | $0.04vs $0.07+154.1% | $209Mvs $203M+3.0% |
| Q3 2025 | Jul 29, 2025 | $0.05vs $0.08-37.5% | $225Mvs $203M+11.2% |
Based on last 12 quarters of dataView full earnings history →
Latest NEOG News
Recent stock market news and headlines for Neogen Corporation (NEOG)
Zacks Investment Research·Jun 25, 2026
Is it Worth Retaining NEOG Stock in Your Portfolio for Now?Neogen has surged over the past year as product launches and 3M Food Safety integration progress, but debt levels and competition remain key concerns.
GuruFocus·Jun 18, 2026
Neogen® Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World ScrewwormNeogen Corporation (NASDAQ: NEOG), an innovative leader in food and animal safety solutions, today announced the expanded availability of FIFRA* Section 2(ee)
Business Wire·Jun 18, 2026
Neogen® Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World ScrewwormLANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG), an innovative leader in food and animal safety solutions, today announced the expanded availability of FIFRA* Section 2(ee) recommendations for the use of Prozap® Insectrin X Concentrate and Prozap® Screw Worm and Ear Tick Aerosol as part of New World Screwworm (NWS) response efforts. These recommendations provide ranchers, livestock producers, and horse owners with an additional option to support fly management efforts. In Tex.
Peers Comparison
Key metrics vs top competitors for Neogen Corporation (NEOG)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $9.39 | $2.04B | -1.87 | -3.2% | -122.06% | -41.88% | — | |
| $570.25 | $45.29B | 43.60 | 10.42% | 24.63% | 70.87% | — | |
| $20.61 | $662.92M | 10.68 | 28.44% | 25.68% | 10.59% | — | |
| $17.00 | $1.16B | -1.02 | -1.89% | -45.57% | -56.31% | — | |
| $9.46 | $1.56B | 3.72 | 64.69% | -14.73% | — | — | |
| $292.50 | $7.9B | 10.50 | 0.65% | 6.52% | 2.4% | — |
Compare NEOG vs Peers
Neogen Corporation (NEOG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NEOG SEC Filings & Documents
Neogen Corporation (NEOG) SEC filings — annual & quarterly reports (10-K, 10-Q)
8-K Announcements
6Material company update
Apr 20, 2026·SEC
Material company update
Apr 9, 2026·SEC
Material company update
Mar 30, 2026·SEC
10-K Annual Reports
210-Q Quarterly Reports
6Get notified when NEOG posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
NEOG Frequently Asked Questions
Neogen Corporation (NEOG) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Neogen Corporation's revenue?
Neogen Corporation (NEOG) reported $870.5M in revenue for fiscal year 2025. This represents a 6864% increase from $12.5M in 1996.
How fast is Neogen Corporation growing?
Neogen Corporation (NEOG) saw revenue decline by 3.2% over the past year.
Is NEOG profitable?
Neogen Corporation (NEOG) reported a net loss of $608.8M for fiscal year 2025.
Dividend & Returns
What is NEOG's return on equity?
Neogen Corporation (NEOG) has a return on equity (ROE) of -41.9%. Negative ROE indicates the company is unprofitable.
What is Neogen Corporation's free cash flow?
Neogen Corporation (NEOG) generated $41.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.